Efficacy of extracorporeal immunoadsorption therapy for removal of HBsAg
Abstract The purpose of chronic hepatitis B (CHB) treatment is functional cure (FC). It refers to the removal of hepatitis B surface antigen (HBsAg) from the serum. However, this outcome is rare with current treatments due to the presence of integrated hepatitis B virus (HBV) DNA and intrahepatic co...
Saved in:
| Main Authors: | Meng Wang, Qi Zhou, Huan Wu, Yefu Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Gastroenterology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-025-04062-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01) -
HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases
by: Zhongshu Pu, et al.
Published: (2025-05-01) -
The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
by: Shengxia Yin, et al.
Published: (2023-12-01) -
Development of Low-Cost In-House Assays for Quantitative Detection of HBsAg, HBeAg, and HBV DNA to Enhance Hepatitis B Virus Diagnostics and Antiviral Screening in Resource-Limited Settings
by: Simmone D’souza, et al.
Published: (2025-03-01) -
基因工程乙肝疫苗的研制——Ⅲ.MT-5细胞的HBsAg纯化与鉴定
Published: (1990-01-01)